NCT03463577View on ClinicalTrials.gov

The Safety of Boostrix Following Routine Immunization of Pregnant Women

CompletedOBSERVATIONAL
Enrollment

65,783

Participants

Timeline

Start Date

April 13, 2018

Primary Completion Date

August 4, 2020

Study Completion Date

August 4, 2020

Conditions
Whooping Cough
Interventions
OTHER

Safety assessment following routine immunization with Boostrix

Subject-level data was collected for pregnant women and their infants through the Electronic Health Records.

Trial Locations (1)

91101

GSK Investigational Site, Pasadena

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
collaborator

Kaiser Permanente

OTHER

lead

GlaxoSmithKline

INDUSTRY

NCT03463577 - The Safety of Boostrix Following Routine Immunization of Pregnant Women | Biotech Hunter | Biotech Hunter